Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Multicentre, Randomized, Controlled Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy

This study has been completed.
Chongqing Taiji Group of Fuling pharmaceutical Co., LTD
Information provided by (Responsible Party):
Chengdu University of Traditional Chinese Medicine Identifier:
First received: April 26, 2011
Last updated: May 10, 2013
Last verified: May 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)